<a href="https://support.doctorpodcasting.com/media/k2/items/cache/66835ee50fc0b8b9f0fe0a0a8518cab7_Generic.jpg"><img align="right" border="0" src="https://support.doctorpodcasting.com/media/k2/items/cache/66835ee50fc0b8b9f0fe0a0a8518cab7_S.jpg" alt="the-business-of-cancer-drug-development" /></a>The pharmaceutical industry's (often misunderstood) role in bringing novel therapies to cancer patients. <br /><br />Guest: David Schenkein, MD, General Partner at GV, Executive Chairman of Agios Pharmaceuticals and Adjunct Attending Physician in Hematology at Tufts Medical Center. Host: John Leonard, MD, world-renowned hematologist and medical oncologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital.

Cancer in the Time of COVID-19

New scientific developments are transforming the future of cancer treatment and care. Hosted by world-renowned hematologist and medical oncologist Dr. John Leonard, CancerCast is your window into research breakthroughs, innovative therapies and honest accounts of living with and beyond cancer. Questions or suggestions? Email us at cancercast@med.cornell.edu.